L. Deleyrolle

Increasing Ciliary ARL13B Expression Drives Active and Inhibitor-Resistant SMO and GLI into Glioma Primary Cilia

This study shows increased ARL13B expression drives active and inhibitor-resistant SMO and GLI into glioma cilia, promoting treatment resistance.

Tumor Treating Fields Suppression of Ciliogenesis Enhances Temozolomide Toxicity

This study shows TTFields reduce cilia in glioma cells, enhancing TMZ toxicity, and that ciliogenesis timing affects treatment outcomes.